Dermatology News: 2007.24

• 2007.24(10) Evaluation of prospectively collected presenting signs/symptoms of biopsy-proven melanoma, basal cell carcinoma, squamous cell carcinoma, and seborrheic keratosis in an elderly male population
  We sought to compare prospectively collected, presenting signs/symptoms of malignant melanoma (MM), basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and seborrheic keratosis (SK)...   |   Read more ...



• 2007.24(9) Lichen planus responding to efalizumab
  Lichen planus (LP) is a common inflammatory skin disorder of unknown origin. When generalized and relapsing, treatment of LP can be a challenge...   |   Read more ...



• 2007.24(8) Eruptive latent metastatic melanomas after initiation of antitumor necrosis factor therapies
  We report two cases of late recurrence of eruptive locoregional metastatic melanoma occurring 6 and 9 years after definitive surgical treatment...   |   Read more ...



• 2007.24(7) The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: A case-control study
  Previous reports demonstrated an association between psoriasis and other diseases including heart failure and diabetes mellitus...   |   Read more ...



• 2007.24(6) Infliximab for severe hidradenitis suppurativa: Transient clinical efficacy in 7 consecutive patients
  Hidradenitis suppurativa (HS) is a chronic and debilitating disorder. Despite its significant prevalence, few reports of therapeutic studies are available...   |   Read more ...



• 2007.24(5) Quality of life impairment in hidradenitis suppurativa: A study of 61 cases
  We sought to determine quality of life impairment in hidradenitis suppurativa. Questionnaires were administered to 61 patients...   |   Read more ...



• 2007.24(4) Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: A 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety
  The long-term effects of botulinum toxin type A (BoNTA) on the global impairment associated with severe primary axillary hyperhidrosis have not been comprehensively assessed relative to placebo...   |   Read more ...



• 2007.24(3) A randomized, open-label trial of continuous versus interrupted etanercept therapy in the treatment of psoriasis
  Although etanercept is used as a continuous therapy for moderate to severe plaque psoriasis, intermittent use may be necessary in some instances...   |   Read more ...



• 2007.24(2) New prognostic relevant factors in primary cutaneous diffuse large B-cell lymphomas
  There is a growing body of literature that has enhanced our understanding of the biology of primary cutaneous diffuse large B-cell lymphoma (PCDLBCL) including in the context of gene profiling studies...   |   Read more ...



• 2007.24(1) Open-label pilot study of combination therapy with rosiglitazone and bexarotene in the treatment of cutaneous T-cell lymphoma
  Four patients with stable or progressive cutaneous T-cell lymphoma treated with oral bexarotene received oral rosiglitazone...   |   Read more ...

    Current Year Archive:   Dermatology News 2007   |   Main Archive:   Dermatology News  

The Derm News service provided by the Editorial Consultants of Skin Therapy Letter^© and its founding editor Dr. Stuart Maddin.